STARBRIGHT

Live / Registered — Registered (as of 06 Jan 2026)

What this means for you

Registered since 06 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97649648
Registration number
8096300
Mark type
Stylized text
Filed
26 Oct 2022
Published for opposition
31 Oct 2023
Registered
06 Jan 2026
Attorney of record
Margaret C. McHugh

Goods and services

  • Class 001 — Chemicals: Fluorescent dyes for scientific or research use; fluorescent dyes for scientific use in life science applications; Dyes, stains, namely, fluorescent dyes and chemicals for labeling or staining biological cells for scientific, laboratory, or research purposes; fluorescent dyes for research use in fluorescent immunoassays (FLISA), cell-based assays, flow cytometry, and fluorescent immunohistochemical staining, and in vivo imaging; proteins for scientific and research use; cell culture proteins for scientific and research use; biochemical, namely, monoclonal antibodies for in vitro scientific and research use; biochemically labelled and enzyme labelled antibodies for use in science; microparticles containing fluorescent dyes for flow cytometry and scientific use; enzyme and chemical labelling molecules for use in science; chemicals, reagents, chemical preparations, and chemical substances all for use in analysis and testing in laboratories other than for medical or veterinary purposes; assays and reagents for use in scientific, laboratory and research purposes; immunoassays in the nature of chemical tests used to detect or quantify analytes using an immunological reaction; chemical agents for use in separation for scientific and research use; cell culture media for use in separation techniques for scientific and research use; Chemical reagent for research purposes, namely, a bioconjugation agent for conjugation and immobilization of peptides, fluorophores, biomolecules, proteins, carbohydrates, DNA/RNA or other molecules; Biochemicals for scientific, laboratory, and research use, namely, proteolytically-activatable, protease-activatable, or proteolytically activated or protease-activated immunoglobulin and antigen-binding fragments for binding to tissue, cells and antigens; biochemical test kits comprising assays and reagents for scientific, laboratory and research purposes; assay kits comprising assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding for scientific, laboratory and research use; conjugation and labelling kits comprised primarily of reagents, antibodies, labelling enzymes and chemicals for performing conjugation and labelling reactions for use in science; reagents in kit form for performing assays for scientific and research use; flow cytometry kits comprised of research reagents, buffers and controls for research laboratory use
  • Class 005 — Pharmaceuticals: Fluorescent dyes and chemicals for medical use; Dyes, stains, namely, fluorescent dyes and chemicals for labeling or staining biological cells for medical purposes; proteins for medical use; cell culture proteins for medical use; monoclonal antibodies for medical use; monoclonal antibodies for in vitro medical use; fluorescent dyes for medical use in fluorescent immunoassays (FLISA), cell-based assays, flow cytometry, and fluorescent immunohistochemical staining, and in vivo imaging; biochemically labelled and enzyme labelled antibodies for medical use; microparticles containing fluorescent dyes for flow cytometry and medical use; chemical and biochemical preparations, assays, dyes, and reagents for clinical and medical laboratory use; chemical reagents for medical purposes for flow cytometry; chemicals, reagents, chemical preparations, and chemical substances all for use in analysis and testing in laboratories for medical purposes; Chemical reagent for medical purposes, namely, a bioconjugation agent for conjugation and immobilization of peptides, fluorophores, biomolecules, proteins, carbohydrates, DNA/RNA or other molecules. chemicals and chemical reagents for medical use; reagents in kit form for performing assays for medical purposes; chemicals agents for use in separation for medical use; cell culture media for use in separation techniques for medical use; biochemical test kits comprising assays and reagents for medical purposes; assay kits comprising assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding for medical purposes; conjugation and labelling kits comprised primarily of reagents, antibodies, labelling enzymes and chemicals for performing conjugation and labelling reactions for medical purposes; flow cytometry kits comprised of research reagents, buffers and controls for medical purposes
  • Class 042 — Scientific and technological services: Chemical analysis and research for others; medical laboratory services; medical testing for medical, scientific and research purposes; research and development services for others in the fields of nucleic acid, protein and antibody conjugation and modification; testing, research, design and development services in the field of biochemicals for scientific and medical research purposes; scientific and technological services, namely, custom conjugation, lateral flow assay development, lateral flow assay creation, and research and design relating to conjugate blocking technology; custom design and formulation in the nature of research, development, product evaluation of chemicals, assays and reagents for separation and purification techniques; providing technical support and consultation services relating to antibody selection and use, namely, providing technical scientific research consultation services

Owner

Prosecution history

  • 06 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 06 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
  • 13 Dec 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 13 Dec 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 12 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 12 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 12 Dec 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
  • 06 Nov 2025 — ASSIGNED TO EXAMINER
  • 12 Sept 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
  • 12 Sept 2025 — FINAL REFUSAL E-MAILED
  • 12 Sept 2025 — SU - FINAL REFUSAL - WRITTEN
  • 02 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 02 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 02 Sept 2025 — ASSIGNED TO LIE
  • 26 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED

View this trademark record on Marksy